The Lipid lowering and Onset of Renal Disease (LORD) Trial: A randomized double blind placebo controlled trial assessing the effect of atorvastatin on the progression of kidney disease

BACKGROUND: There is evidence that dyslipidemia is associated with chronic kidney disease (CKD). Experimental studies have established that lipids are damaging to the kidney and animal intervention studies show statins attenuate this damage. Small clinical trials, meta-analyses, observational studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Fassett, Robert G, Ball, Madeleine J, Robertson, Iain K, Geraghty, Dominic P, Coombes, Jeff S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276485/
https://www.ncbi.nlm.nih.gov/pubmed/18366658
http://dx.doi.org/10.1186/1471-2369-9-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276485/
https://www.ncbi.nlm.nih.gov/pubmed/18366658
http://dx.doi.org/10.1186/1471-2369-9-4

Ejemplares similares